跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
許 惠晴
助理教授
,
過敏免疫風濕科
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0002-1093-6019
電子郵件
ciangthearm19
tmu.edu
tw
,
102146
w.tmu.edu
tw
h-index
178
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2018
2025
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(16)
類似的個人檔案
(7)
指紋
查看啟用 Hui-Ching Hsu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Autoimmune Disease
98%
Hazard Ratio
82%
Cohort Analysis
78%
Appendectomy
31%
Sjoegren Syndrome
27%
Rheumatoid Arthritis
25%
Biological Product
23%
Lupus Erythematosus
22%
Disease
21%
Chronic Hepatitis C
19%
Hip Replacement
19%
Pneumocystis Jirovecii
19%
Autoimmune Rheumatic Disease
19%
Proton-Pump Inhibitor
19%
Thymectomy
19%
Allergic Rhinitis
19%
Third-Degree Atrioventricular Block
19%
Total Knee Arthroplasty
19%
Parkinson's Disease
19%
La Antibody
19%
Interferon
19%
Rheumatic Disease
19%
Proportional Hazards Model
16%
Infection
14%
Refractory Period
13%
Afferent Nerve Fiber
13%
Nerve Fiber
13%
Tonsillectomy
11%
Hepatitis C
10%
Membranous Glomerulonephritis
9%
Symptom
9%
Systemic Lupus Erythematosus
9%
Immune Function
9%
Population
9%
Dermatomyositis
7%
Polymyositis
7%
Dysbiosis
7%
Immune System
6%
Graves' Disease
6%
Nerve Excitability
6%
Clinical Trial
6%
Compound Muscle Action Potential
6%
Peripheral Neuropathy
6%
Axon
6%
Nerve Conduction Study
6%
Autoantibodies
6%
Excitability
6%
Peripheral Nerve
6%
Pathophysiology
6%
Action Potential
6%
Immunology and Microbiology
Autoimmune Disease
100%
Comorbidity
50%
Systemic Lupus Erythematosus
42%
Sjögren's Syndrome
40%
Inflammatory Arthritis
34%
Lupus Erythematosus
29%
Population
26%
Thyroiditis
22%
Autoimmune Rheumatic Disease
19%
Macrophage
19%
Interleukin 6
19%
Interferon Type I
19%
La Antibody
19%
Pneumocystis Jiroveci
19%
Arthritis
19%
Autophagy
19%
Allergic Rhinitis
19%
Gout
19%
Hepatitis C
19%
Rheumatic Disease
19%
Autoimmune Hemolytic Anemia
16%
Immune System
15%
Nerve Fiber
13%
Sensory Nerve
13%
Refractory Period
13%
Appendix
12%
Prevalence
12%
Ankylosing Spondylitis
12%
Vasculitis
11%
Mucosa
9%
Atopic Dermatitis
9%
Microflora
9%
Allergic Asthma
9%
Gut-Associated Lymphoid Tissue
9%
Tonsil
9%
Myasthenia gravis
9%
Graves' Disease
9%
Dermatomyositis
7%
Polymyositis
7%
Systemic Scleroderma
7%
Nerve Excitability
6%
Nerve Conduction
6%
Monospecific Antibody
6%
Peripheral Nerve
6%
Muscle Action Potential
6%
Autoantibodies
6%
Axon
6%
Antibody Titer
6%
Action Potential
6%
Excitability
6%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
59%
Cohort Study
47%
Sjoegren Syndrome
39%
Hepatitis C
30%
Thyroiditis
22%
Psoriasis
22%
Chronic Hepatitis C
19%
Histamine H1 Receptor Antagonist
19%
Virus Hepatitis
19%
Liver Cell Carcinoma
19%
Hepatitis B Virus
19%
Hepatitis C Virus
19%
Proton Pump Inhibitor
19%
Jaw Osteonecrosis
19%
Bisphosphonic Acid Derivative
19%
Pneumocystis Jiroveci
19%
Rheumatic Disease
19%
Interferon
19%
Sulfonylurea
19%
Thiazolidinedione
19%
Dipeptidyl Peptidase IV Inhibitor
19%
Non Insulin Dependent Diabetes Mellitus
19%
Systemic Lupus Erythematosus
17%
Antihistaminic Agent
16%
Autoimmune Hemolytic Anemia
15%
Infection
12%
Rheumatoid Arthritis
10%
Systemic Vasculitis
10%
Comorbidity
9%
Myasthenia gravis
9%
Ankylosing Spondylitis
9%
Dermatomyositis
7%
Polymyositis
7%
Addison Disease
6%
Systemic Sclerosis
6%
Graves Disease
6%
Cyclophosphamide
5%
Mycophenolic Acid
5%
